| Dr Diego A Diaz, MD | |
|
110 E 59th St, Suite 9c, New York, NY 10022-1304 | |
| (212) 583-2850 | |
| (212) 644-8666 |
| Full Name | Dr Diego A Diaz |
|---|---|
| Gender | Male |
| Speciality | Sleep Medicine |
| Experience | 35 Years |
| Location | 110 E 59th St, New York, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942270467 | NPI | - | NPPES |
| 01884284 | Medicaid | NY | |
| 211166 | Other | NY | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 211166 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vns Of Ny Home Care Chha | New york, NY | Home health agency |
| Lenox Hill Hospital | New york, NY | Hospital |
| Entity Name | Sleep And Breathing Disorders Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770861031 PECOS PAC ID: 7214197755 Enrollment ID: O20120321000190 |
News Archive
The U.N. Commission on Information and Accountability for Women's and Children's Health on Monday concluded a meeting in Dar es Salaam, Tanzania, and announced a new set of recommendations aimed at improving the accountability of women's and children's health programs in the developing world, PANA/Afrique en ligne reports.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
According to research published online in The FASEB Journal, scientists have discovered a dual peptide called "PGLP-1" that promotes insulin secretion and inhibits gluconeogenesis.
The Obama administration hires a credit reporting agency to verify the incomes of people who apply for federal subsidies to buy health insurance. Meanwhile, Missouri Gov. Jay Nixon signs a bill that could make it more difficult to do enrollment outreach there, as federal officials consider ways to implement the law in states led by officials opposed to it.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Diego A Diaz Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689122913 PECOS PAC ID: 7416230206 Enrollment ID: O20170201000671 |
News Archive
The U.N. Commission on Information and Accountability for Women's and Children's Health on Monday concluded a meeting in Dar es Salaam, Tanzania, and announced a new set of recommendations aimed at improving the accountability of women's and children's health programs in the developing world, PANA/Afrique en ligne reports.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
According to research published online in The FASEB Journal, scientists have discovered a dual peptide called "PGLP-1" that promotes insulin secretion and inhibits gluconeogenesis.
The Obama administration hires a credit reporting agency to verify the incomes of people who apply for federal subsidies to buy health insurance. Meanwhile, Missouri Gov. Jay Nixon signs a bill that could make it more difficult to do enrollment outreach there, as federal officials consider ways to implement the law in states led by officials opposed to it.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Lifeline Medical Testing Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114634482 PECOS PAC ID: 1557726767 Enrollment ID: O20230421002138 |
News Archive
The U.N. Commission on Information and Accountability for Women's and Children's Health on Monday concluded a meeting in Dar es Salaam, Tanzania, and announced a new set of recommendations aimed at improving the accountability of women's and children's health programs in the developing world, PANA/Afrique en ligne reports.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
According to research published online in The FASEB Journal, scientists have discovered a dual peptide called "PGLP-1" that promotes insulin secretion and inhibits gluconeogenesis.
The Obama administration hires a credit reporting agency to verify the incomes of people who apply for federal subsidies to buy health insurance. Meanwhile, Missouri Gov. Jay Nixon signs a bill that could make it more difficult to do enrollment outreach there, as federal officials consider ways to implement the law in states led by officials opposed to it.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diego A Diaz, MD 110 E 59th St, Suite 9c, New York, NY 10022-1304 Ph: (212) 583-2850 | Dr Diego A Diaz, MD 110 E 59th St, Suite 9c, New York, NY 10022-1304 Ph: (212) 583-2850 |
News Archive
The U.N. Commission on Information and Accountability for Women's and Children's Health on Monday concluded a meeting in Dar es Salaam, Tanzania, and announced a new set of recommendations aimed at improving the accountability of women's and children's health programs in the developing world, PANA/Afrique en ligne reports.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
According to research published online in The FASEB Journal, scientists have discovered a dual peptide called "PGLP-1" that promotes insulin secretion and inhibits gluconeogenesis.
The Obama administration hires a credit reporting agency to verify the incomes of people who apply for federal subsidies to buy health insurance. Meanwhile, Missouri Gov. Jay Nixon signs a bill that could make it more difficult to do enrollment outreach there, as federal officials consider ways to implement the law in states led by officials opposed to it.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
Dr. Ravishankar Ramaswamy, MD, MS Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737 | |
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692 | |
Dr. Rakhshan Mahmood Chida, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690 | |
Charles D Resor, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913 | |
Dr. Jacqueline Yuey Lonier, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494 | |
Dr. Sharon Uralil, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-3293 | |
Diana Kantor, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550 |